Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-35.95%
↓ 113% vs avg
Percentile
P27
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-16.88%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -35.95% |
| Q2 2025 | 28.41% |
| Q1 2025 | -19.48% |
| Q4 2024 | -36.25% |
| Q3 2024 | -9.48% |
| Q2 2024 | 3.32% |
| Q1 2024 | -37.95% |
| Q4 2023 | -65.94% |
| Q3 2023 | -1.14% |
| Q2 2023 | 1.97% |
| Q1 2023 | -30.09% |
| Q4 2022 | 0.00% |